EUVIMEDEUVIMED entdecken
Vergleichsstudie

The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults

Zixiang Ye, Haixu Wang, Enmin Xie, Zeming Zhou, Kefei Dou

American Journal of Nephrology · 2025

DOI: 10.1159/000542912 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Zixiang Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…. Hauptthemen laut MEDLINE: Cystatin C, Cardiovascular Diseases, Renal Insufficiency, Chronic. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

We intended to compare the predictive value for all-cause and cardiovascular deaths between estimated glomerular filtration rate (eGFR) derived from the European Kidney Function Consortium (EKFC) cystatin C-based formula, the EKFC creatinine-based formula, and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) cystatin C- or creatinine-based formulas.

Methods

Overall, 4,132 participants from the National Health and Nutrition Examination Survey between 1999 and 2002 were included, and death information was obtained through the National Death Index. To compare predictive accuracy between EKFC eGFRcys (EKFC cystatin C-based formula), CKD-EPI eGFRcys (CKD-EPI cystatin C-based formula), EKFC eGFRcr (EKFC creatinine-based formula), and CKD-EPI eGFRcr (CKD-EPI creatinine-based formula), we conducted time-dependent receiver operator characteristic (ROC) curves and reclassification analysis.

Results

During a median follow-up of 17.4 years, a total of 1,987 all-cause and 530 cardiovascular deaths were confirmed. Restricted cubic splines analyses showed that reduced EKFC eGFRcys was linearly related to higher risks of all-cause and cardiovascular deaths (p for nonlinearity > 0.05). Time-dependent ROC curves suggested that EKFC eGFRcys exhibited higher predictive ability than CKD-EPI eGFRcys, EKFC eGFRcr, and CKD-EPI eGFRcr at 5-year and 10-year follow-ups. For 10-year all-cause deaths, EKFC eGFRcys yielded significant improvement over CKD-EPI eGFRcr (integrated discrimination improvement [IDI], 9.4%; net reclassification improvement [NRI], 39.7%). Similar improvement was observed in 10-year cardiovascular deaths when comparing EKFC eGFRcys to CKD-EPI eGFRcr (IDI, 6.7%; NRI, 45.1%).

Conclusion

The EKFC eGFRcys outperformed CKD-EPI eGFRcys, EKFC eGFRcr, and CKD-EPI eGFRcr in predicting all-cause and cardiovascular deaths, providing the possibility to utilize EKFC eGFRcys in the stratification of death risk among the general US population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystatin CCardiovascular DiseasesRenal Insufficiency, ChronicHumansMaleFemaleMiddle AgedUnited StatesGlomerular Filtration RateCreatinineRisk AssessmentAgedAdultCause of DeathNutrition SurveysPredictive Value of TestsROC Curve

Stichwörter der Autor:innen

CKD-EPIDeathEKFCGlomerular filtration ratePrediction

Substanzen

Cystatin CCreatinine

Autor:innen und Institutionen

  • Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Ca…

Zitieren

APA

Ye, Z., Wang, H., Xie, E., Zhou, Z., & Dou, K. (2025). The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults. American Journal of Nephrology. https://doi.org/10.1159/000542912

Vancouver

Ye Z, Wang H, Xie E, Zhou Z, Dou K. The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults. American Journal of Nephrology. 2025. doi:10.1159/000542912

BibTeX
@article{Ye2025,
  author = {Ye, Zixiang and Wang, Haixu and Xie, Enmin and Zhou, Zeming and Dou, Kefei},
  title = {The Superiority of European Kidney Function Consortium Cystatin C-Based Formula for Risk Stratification of All-Cause and Cardiovascular Deaths in US Adults},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000542912}
}
Kostenlos starten →